UniProt ID | PIAS3_HUMAN | |
---|---|---|
UniProt AC | Q9Y6X2 | |
Protein Name | E3 SUMO-protein ligase PIAS3 | |
Gene Name | PIAS3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 628 | |
Subcellular Localization | Cytoplasm . Nucleus . Nucleus speckle . Colocalizes with MITF in the nucleus. Colocalizes with GFI1 in nuclear dots. Colocalizes with SUMO1 in nuclear granules. | |
Protein Description | Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway and the steroid hormone signaling pathway. Involved in regulating STAT3 signaling via inhibiting STAT3 DNA-binding and suppressing cell growth. Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation. [PubMed: 21965678] | |
Protein Sequence | MAELGELKHMVMSFRVSELQVLLGFAGRNKSGRKHELLAKALHLLKSSCAPSVQMKIKELYRRRFPRKTLGPSDLSLLSLPPGTSPVGSPGPLAPIPPTLLAPGTLLGPKREVDMHPPLPQPVHPDVTMKPLPFYEVYGELIRPTTLASTSSQRFEEAHFTFALTPQQVQQILTSREVLPGAKCDYTIQVQLRFCLCETSCPQEDYFPPNLFVKVNGKLCPLPGYLPPTKNGAEPKRPSRPINITPLARLSATVPNTIVVNWSSEFGRNYSLSVYLVRQLTAGTLLQKLRAKGIRNPDHSRALIKEKLTADPDSEVATTSLRVSLMCPLGKMRLTVPCRALTCAHLQSFDAALYLQMNEKKPTWTCPVCDKKAPYESLIIDGLFMEILSSCSDCDEIQFMEDGSWCPMKPKKEASEVCPPPGYGLDGLQYSPVQGGDPSENKKKVEVIDLTIESSSDEEDLPPTKKHCSVTSAAIPALPGSKGVLTSGHQPSSVLRSPAMGTLGGDFLSSLPLHEYPPAFPLGADIQGLDLFSFLQTESQHYGPSVITSLDEQDALGHFFQYRGTPSHFLGPLAPTLGSSHCSATPAPPPGRVSSIVAPGGALREGHGGPLPSGPSLTGCRSDIISLD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAELGELKH ------CCCHHHHHH | 22.26 | - | |
8 | Ubiquitination | MAELGELKHMVMSFR CCCHHHHHHHHHHCC | 25.92 | - | |
13 | Phosphorylation | ELKHMVMSFRVSELQ HHHHHHHHCCHHHHH | 9.86 | 24719451 | |
34 | Ubiquitination | GRNKSGRKHELLAKA CCCCCCCHHHHHHHH | 44.98 | - | |
46 | Sumoylation | AKALHLLKSSCAPSV HHHHHHHHHCCCCHH | 46.84 | - | |
46 | Sumoylation | AKALHLLKSSCAPSV HHHHHHHHHCCCCHH | 46.84 | 28112733 | |
56 | Sumoylation | CAPSVQMKIKELYRR CCCHHHHHHHHHHHH | 33.27 | - | |
56 | Ubiquitination | CAPSVQMKIKELYRR CCCHHHHHHHHHHHH | 33.27 | - | |
56 | Sumoylation | CAPSVQMKIKELYRR CCCHHHHHHHHHHHH | 33.27 | 28112733 | |
58 | Sumoylation | PSVQMKIKELYRRRF CHHHHHHHHHHHHHC | 35.83 | - | |
58 | Sumoylation | PSVQMKIKELYRRRF CHHHHHHHHHHHHHC | 35.83 | - | |
58 | Ubiquitination | PSVQMKIKELYRRRF CHHHHHHHHHHHHHC | 35.83 | - | |
84 | Phosphorylation | LLSLPPGTSPVGSPG HHCCCCCCCCCCCCC | 35.31 | 28348404 | |
85 | Phosphorylation | LSLPPGTSPVGSPGP HCCCCCCCCCCCCCC | 24.41 | 28348404 | |
89 | Phosphorylation | PGTSPVGSPGPLAPI CCCCCCCCCCCCCCC | 27.24 | 28348404 | |
165 | Phosphorylation | AHFTFALTPQQVQQI CCEEEECCHHHHHHH | 18.67 | 22210691 | |
174 | Phosphorylation | QQVQQILTSREVLPG HHHHHHHHCCCCCCC | 27.63 | 22210691 | |
183 | Acetylation | REVLPGAKCDYTIQV CCCCCCCCCCEEEEE | 33.29 | 26051181 | |
183 | Ubiquitination | REVLPGAKCDYTIQV CCCCCCCCCCEEEEE | 33.29 | - | |
230 | Sumoylation | PGYLPPTKNGAEPKR CCCCCCCCCCCCCCC | 60.19 | - | |
230 | Sumoylation | PGYLPPTKNGAEPKR CCCCCCCCCCCCCCC | 60.19 | 28112733 | |
236 | Ubiquitination | TKNGAEPKRPSRPIN CCCCCCCCCCCCCCC | 69.33 | - | |
288 | Sumoylation | TAGTLLQKLRAKGIR HHHHHHHHHHHCCCC | 39.65 | - | |
288 | Ubiquitination | TAGTLLQKLRAKGIR HHHHHHHHHHHCCCC | 39.65 | - | |
288 | Sumoylation | TAGTLLQKLRAKGIR HHHHHHHHHHHCCCC | 39.65 | - | |
295 | Asymmetric dimethylarginine | KLRAKGIRNPDHSRA HHHHCCCCCCHHHHH | 58.24 | - | |
300 | Phosphorylation | GIRNPDHSRALIKEK CCCCCHHHHHHHHHH | 26.99 | 22964224 | |
305 | Ubiquitination | DHSRALIKEKLTADP HHHHHHHHHHHCCCC | 50.04 | - | |
307 | Ubiquitination | SRALIKEKLTADPDS HHHHHHHHHCCCCCC | 46.25 | 21906983 | |
307 | Sumoylation | SRALIKEKLTADPDS HHHHHHHHHCCCCCC | 46.25 | - | |
307 | Sumoylation | SRALIKEKLTADPDS HHHHHHHHHCCCCCC | 46.25 | 28112733 | |
331 | Sumoylation | SLMCPLGKMRLTVPC EEECCCCCCEEECCC | 28.64 | - | |
331 | Ubiquitination | SLMCPLGKMRLTVPC EEECCCCCCEEECCC | 28.64 | - | |
331 | Sumoylation | SLMCPLGKMRLTVPC EEECCCCCCEEECCC | 28.64 | - | |
361 | Sumoylation | YLQMNEKKPTWTCPV HHHCCCCCCCEECCC | 41.31 | - | |
361 | Sumoylation | YLQMNEKKPTWTCPV HHHCCCCCCCEECCC | 41.31 | - | |
372 | Ubiquitination | TCPVCDKKAPYESLI ECCCCCCCCCHHHEE | 41.15 | - | |
415 | Phosphorylation | MKPKKEASEVCPPPG CCCCCCHHCCCCCCC | 31.49 | 23312004 | |
423 | Phosphorylation | EVCPPPGYGLDGLQY CCCCCCCCCCCCCCC | 21.93 | 29978859 | |
430 | Phosphorylation | YGLDGLQYSPVQGGD CCCCCCCCCCCCCCC | 21.71 | 25159151 | |
431 | Phosphorylation | GLDGLQYSPVQGGDP CCCCCCCCCCCCCCC | 12.97 | 25849741 | |
439 | Phosphorylation | PVQGGDPSENKKKVE CCCCCCCCCCCCEEE | 59.55 | 29978859 | |
442 | Ubiquitination | GGDPSENKKKVEVID CCCCCCCCCEEEEEE | 50.33 | - | |
443 | Ubiquitination | GDPSENKKKVEVIDL CCCCCCCCEEEEEEE | 73.89 | - | |
451 | Phosphorylation | KVEVIDLTIESSSDE EEEEEEEEEECCCCC | 20.96 | 28102081 | |
454 | Phosphorylation | VIDLTIESSSDEEDL EEEEEEECCCCCCCC | 31.15 | 28102081 | |
455 | Phosphorylation | IDLTIESSSDEEDLP EEEEEECCCCCCCCC | 29.08 | 28102081 | |
456 | Phosphorylation | DLTIESSSDEEDLPP EEEEECCCCCCCCCC | 59.32 | 28102081 | |
464 | Phosphorylation | DEEDLPPTKKHCSVT CCCCCCCCCCCCCCC | 51.27 | 28102081 | |
466 | Sumoylation | EDLPPTKKHCSVTSA CCCCCCCCCCCCCCC | 52.93 | 28112733 | |
466 | Ubiquitination | EDLPPTKKHCSVTSA CCCCCCCCCCCCCCC | 52.93 | - | |
469 | Phosphorylation | PPTKKHCSVTSAAIP CCCCCCCCCCCCCCC | 28.31 | 23532336 | |
471 | Phosphorylation | TKKHCSVTSAAIPAL CCCCCCCCCCCCCCC | 9.06 | 23532336 | |
472 | Phosphorylation | KKHCSVTSAAIPALP CCCCCCCCCCCCCCC | 17.34 | 23532336 | |
482 | Ubiquitination | IPALPGSKGVLTSGH CCCCCCCCCCCCCCC | 59.98 | - | |
482 | Sumoylation | IPALPGSKGVLTSGH CCCCCCCCCCCCCCC | 59.98 | 28112733 | |
492 | Phosphorylation | LTSGHQPSSVLRSPA CCCCCCCCHHHCCCC | 26.89 | - | |
497 | Phosphorylation | QPSSVLRSPAMGTLG CCCHHHCCCCCCCCC | 16.92 | 23532336 | |
595 | Phosphorylation | PPPGRVSSIVAPGGA CCCCCEEEEEECCCC | 20.44 | 28857561 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PIAS3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PIAS3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TF65_HUMAN | RELA | physical | 15140884 | |
SMAD2_HUMAN | SMAD2 | physical | 14691252 | |
SMAD3_HUMAN | SMAD3 | physical | 14691252 | |
SMAD4_HUMAN | SMAD4 | physical | 14691252 | |
MITF_HUMAN | MITF | physical | 11709556 | |
HMGA2_HUMAN | HMGA2 | physical | 11390395 | |
GFI1_HUMAN | GFI1 | physical | 11060035 | |
TRI32_HUMAN | TRIM32 | physical | 17987106 | |
ZMIZ2_HUMAN | ZMIZ2 | physical | 20159969 | |
CHSP1_HUMAN | CARHSP1 | physical | 21900206 | |
UBA1_HUMAN | UBA1 | physical | 21900206 | |
PRS4_HUMAN | PSMC1 | physical | 21900206 | |
CS060_HUMAN | C19orf60 | physical | 21900206 | |
RAC1_HUMAN | RAC1 | physical | 20935639 | |
STAT3_HUMAN | STAT3 | physical | 12804609 | |
STAT3_MOUSE | Stat3 | physical | 9388184 | |
STAT3_HUMAN | STAT3 | physical | 9724754 | |
ZPI_HUMAN | SERPINA10 | physical | 21988832 | |
STAT3_HUMAN | STAT3 | physical | 21988832 | |
UBC9_HUMAN | UBE2I | physical | 21988832 | |
TAB2_HUMAN | TAB2 | physical | 24096733 | |
HIC1_HUMAN | HIC1 | physical | 23704280 | |
TF65_HUMAN | RELA | physical | 22649547 | |
BC11A_HUMAN | BCL11A | physical | 18681895 | |
SMUF2_HUMAN | SMURF2 | physical | 26679521 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...